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Abstract
It has been postulated that alcoholism is associated with abnormalities in glutamatergic
neurotransmission. This study examined the density of glutamate NMDA receptor subunits and its
associated proteins in the noradrenergic locus coeruleus (LC) in deceased alcoholic subjects. Our
previous research indicated that the NMDA receptor in the human LC is composed of obligatory
NR1 and regulatory NR2C subunits. At synapses, NMDA receptors are stabilized through
interactions with postsynaptic density protein (PSD-95). PSD-95 provides structural and functional
coupling of the NMDA receptor with neuronal nitric oxide synthase (nNOS), an intracellular
mediator of NMDA receptor activation. LC tissue was obtained from 10 alcohol-dependent subjects
and 8 psychiatrically healthy controls. Concentrations of NR1 and NR2C subunits, as well as PSD-95
and nNOS, were measured using Western blotting. In addition we have examined tyrosine
hydroxylase (TH), the rate-limiting enzyme in the synthesis of norepinephrine. The amount of NR1
was lower in the rostral (−30%) and middle (−41%)portions of the LC of alcoholics as compared to
control subjects. No differences in the amounts of NR2C, PSD-95, nNOS and TH were detected
comparing alcoholic to control subjects. Lower levels of NR1 subunit of the NMDA receptor in the
LC implicates altered glutamate-norepinephrine interactions in alcoholism.
Keywords
glutamate; NMDA receptor; postsynaptic density protein 95; neuronal nitric oxide synthase; tyrosine
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1. Introduction
Accumulating evidence suggests that neurophysiological and pathological effects of ethanol
are mediated, at least in part, through the glutamatergic system. NMDA receptors are among
the highest affinity ethanol targets in the brain Grant and Lovinger, 1995. Ethanol inhibits
NMDA receptor function and this effect does not appear to be mediated by any of the well-
characterized binding sites on the receptor (e.g. glutamate, glycine, phencyclidine, polyamine
sites). Instead, recombinant receptor studies have shown that ethanol may have a selective
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effect on specific NMDA receptor subunits, with different effects on certain subunit
combinations (Jin and Woodward, 2006; Kumari and Ticku, 2000).
NMDA receptors are heteromeric proteins assembled from NR1 and NR2 subunits and, less
commonly, the NR3 subunit. The NR2 family contains 4 subunits (A-D) that arise from
separate genes. The NR1 subunit has 8 splice variants that are generated by alternative splicing
of exon 5, 21, and 22 (Zukin and Bennett, 1995). Both NR1 and NR2 subunits are required to
form functional NMDA receptors. The subunit composition of the NMDA receptor affects a
number of physiological and pharmacological properties of the NMDA receptor including
sensitivity to inhibition by ethanol (Chu et al., 1995; Jin and Woodward 2006).
The locus coeruleus (LC), the major source of norepinephrine in the brain, is regulated by
excitatory glutamatergic input from the nucleus paragiganocellularis and medial prefrontal
cortex (Aston-Jones et al., 1991; Ennis and Aston-Jones, 1986; Jodo et al., 1998). LC activity
is inhibited by ethanol (Aston-Jones et al., 1982; Shefner and Tabakoff, 1985) possibly in part
through inhibition of glutamatergic activation of the LC. Our previous study revealed that the
NMDA receptor in the human LC is predominantly composed of NR1/NR2C subunits
(Karolewicz et al., 2005). Based on recombinant receptor studies, NMDA receptors composed
of NR1/NR2C subunits have a lower current amplitude, shorter open time, smaller single
conductance, and reduced sensitivity to Mg2+ (Ishii et al., 1993; Kutsuwada et al. 1992; Laurie
and Seeburg, 1994; Monyer et al., 1994). The relevance of these recombinant studies to the
function of NMDA receptors in the LC is unknown. A recent study demonstrated an elevated
concentration of the NR2C subunit in the LC from major depressive subjects as compared to
normal control subjects (Karolewicz et al., 2005). These findings imply that altered subunit
composition of the NMDA receptor in the LC may contribute to disruption of noradrenergic
transmission in psychiatric illnesses.
There have been no previous studies of NMDA receptor subunits and its associated proteins
in postmortem tissue of alcohol dependent subjects. Rather, investigators have investigated the
effects of chronic exposure of rodents to ethanol on the expression of NMDA receptor
polypeptides (for review see Kumari and Ticku, 2000). Therefore, the present study was
designed to determine whether alcoholism is associated with abnormalities of NMDA receptor
subunits in the LC. In addition, signaling molecules linked to NMDA receptor activation were
also evaluated. At glutamatergic synapses, NMDA receptors are stabilized through interactions
with postsynaptic density protein-95 (PSD-95). PSD-95 immobilizes the NMDA receptor and
serves as a scaffold for the assembly of macromolecular complexes that modulate the receptor’s
transduction pathways, including it’s coupling to neuronal nitric oxide synthase, nNOS
(Brenman et al., 1996; Kornau et al., 1995). Concentrations of NR1 and NR2C subunits as well
as PSD-95 and nNOS were measured in LC tissue from alcohol dependent and healthy control
subjects using Western blotting. In addition, tyrosine hydroxylase (TH), the rate limiting
enzyme in the synthesis of norepinephrine, was measured in the same study subjects.
2. Methods
2.1. Human subjects
Brain tissue was obtained at autopsy at the Coroner's Office of Cuyahoga County, Cleveland,
OH, USA. An ethical protocol approved by the Institutional Review Boards at Case Western
Reserve University and the University of Mississippi Medical Center was used and informed
written consent was obtained from the next of kin for all subjects. Retrospective, informant-
based psychiatric assessments were performed for all alcohol dependent subjects and healthy
controls. A trained interviewer administered the Schedule for Affective Disorders and
Schizophrenia: lifetime version (SADS-L) to knowledgeable next of kin of 4 alcoholics. The
Structured Clinical Interview for DSM-IV Psychiatric Disorders (SCID-IV) was administered
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to next of kin of the 6 remaining alcohol dependent subjects. Blood and urine samples from
all subjects were examined by coroner’s office for psychotropic medications and substances
of abuse, including ethanol. Control subjects (n=8) did not meet criteria for any Axis I disorder
at the time of death, except for nicotine dependence as noted (Table 1). Based on the next of
kin assessment, all alcohol dependent subjects (n=10) were described as long-term “heavy”
drinkers. The onset age of drinking was reported to occur between the teen years and the 20s
for almost all alcohol dependent subjects. Nine of the 10 alcohol dependent subjects were
consuming large quantities of alcohol daily until death. Available data indicate that only one
alcohol dependent subject was abstaining from ethanol for 3 weeks before death. Only 2 out
of the ten subjects had historical information indicating signs of withdrawal (sweating, tremors)
when unsuccessfully attempting to discontinue their habitual drinking. Subjects were matched
across groups as closely as possible for age, gender, postmortem interval, smoking and tissue
pH (Table 1). The paired design was maintained throughout all experimental procedures.
Additionally, body mass index (BMI) was computed as the ratio between body weight (kg)
and height (m2).
2.2. Dissection and anatomical positioning of measurements
LC tissue blocks were sectioned according to a method published previously (Karolewicz et
al., 2004; 2005). Frozen tissue blocks were cut along the entire length of the LC, with
histological sections taken at 1 mm intervals to evaluate anatomical position along the LC axis.
The exact location of the rostral and caudal end of the LC was individualized for each subject
based on cresyl violet (Nissl) staining and subsequent cell counting. The LC had its rostral
border defined as a point where at least 25 ± 5 neuromelanin-containing cells were identified.
The caudal border was defined near the caudal end at a point where 25 ± 5 or less neuromelanin-
containing cells were present. The whole LC was punched into 50 µm thick sections. Tissue
punches were collected in centrifuge tubes and stored at −80° C until assayed.
For each anatomical level of the LC, tissue was collected from 2 mm of sections that were each
centered at points that represented 25%, 50%, and 75% of the total rostro-caudal length of the
LC. Semi-quantitative estimation of neuromelanin-containing cell profiles was performed
using cresyl violet stained sections (20 µm) cut at 1 mm intervals along the LC. Counts are
reported as the average of the left and right LC (Figure 4).
2.3. Immunoblotting
LC tissue samples were prepared according to a method published previously (Karolewicz et
al., 2005). Samples were homogenized in ice-cold TE buffer (10 mM Tris-HCl and 1 mM
ethylene-diaminetetraacetate, EDTA) containing protease inhibitors (Protease Inhibitor
Cocktail Tablets - Complete™, Boehringer Mannheim GmbH). Total protein concentrations
for all samples were determined using the bicinchoninic acid (BCA) method (#23227; Pierce).
Samples were mixed with sample buffer (125 mM Tris base, 20% glycerol, 4% SDS, 10%
mercaptoethanol, 0.05% bromophenol blue, pH 6.8) and heated at 95°C for 8 min. Solubilized
protein (20 µg per lane) was subjected to 10% Criterion Precast Tris-HCl gel electrophoresis
(#345-0009; Bio-Rad Laboratories) and transferred to nitrocellulose membranes (Hybond
ECL; #RPN303D; Amersham Biosciences). After transfer, blots were blocked in 5% non-fat
milk/TBS (20 mM Tris base and 0.5 M NaCl, pH 7.5) or 5% non-fat milk/PBS (137 mM NaCl,
2.7 mM KCl, 8 mM Na2HPO4 and KH2PO4, pH 7.4) for 2 h, then incubated (overnight at 4°
C) with mouse anti-NR1 monoclonal antibodies diluted 1:1000 (# 556308; Pharmingen/BD
Biosciences). NR2C subunit was labeled using rabbit polyclonal antibodies diluted 1:500 (#
OPA1-04020; Affinity BioReagents). PSD-95 was labeled using a mouse monoclonal antibody
diluted 1:1000 (# 05-494; Upstate Cell Signaling). nNOS was labeled using mouse monoclonal
antibodies diluted 1:1000 (# 610309; BD Transduction Laboratories/BD Biosciences). TH was
labeled using a mouse monoclonal antibody diluted 1:1000 (# MAB318; Chemicon
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International). Membranes were washed three times for 10 min in TBS (or PBS) buffer and
incubated with secondary anti-mouse antibody for NR1, PSD-95, nNOS, TH (diluted 1:2000;
# NA931; Amersham Biosciences) and anti-rabbit secondary antibody for NR2C (diluted
1:3000; # NA934; Amersham Biosciences). After incubation, blots were washed 3 times for
15 min and developed using enhanced chemiluminescence detection (ECL; #NEL104;
PerkinElmer) and immediately exposed to film (Hyperfilm-ECL; #RPN3103K; Amersham
Biosciences). As a control for transfer and loading, actin was detected on each blot using an
anti-actin mouse monoclonal antibody diluted 1:5000 (# MAB1501; Chemicon International).
Immunoreactivity of NR1, NR2C, PSD-95, nNOS and TH was investigated in pairs of the
same alcohol dependent and matched control subjects. Pairs of subjects were immunoblotted
on the same gel with duplicates on the separate gels. All results were generated from the rostral,
middle and caudal portions of the LC. Each gel was loaded with 3 concentrations of LC standard
(dissected from a healthy control subject) consisting of 10, 20, and 40 µg of total protein.
2.4. Relationship between the optical density and the total protein concentration
In order to determine the relationship between optical density values and the concentrations of
protein immunoreactivities, 10, 20, and 40 µg of total LC protein (LC standard) was
immunoblotted with anti-NR1, anti-NR2C, anti-PSD-95, anti-nNOS, anti-TH, and anti-actin
antibodies (Figure 2). Optical density values of immunoreactive bands were measured and are
presented as a function of total LC protein concentration (expressed in µg). Analyses of blots
revealed an approximately 1:1 relationship between changes in optical density values and
changes in protein concentrations. That is, a 100% increase in total protein loading resulted in
an approximately 100% increase in the optical density of all protein immunoreactive bands
(Figure 1).
2.5. Statistical analysis
Band densities were analyzed using MCID Elite 7.0 (Imaging Research, St. Catherines,
Ontario, Canada). Relative optical density values were converted to arbitrary protein units
using the standards, normalizing with actin immunoreactivity on the same gel. Data from each
set of experiments, i.e. for each protein measured, were analyzed using one-way ANOVA
followed by Bonferroni post tests for regional differences (GraphPad Prism 4.0, GraphPad
Software Incorporated, San Diego, CA). Summary statistics are reported as the mean ± S.E.M.
Linear regression analyses were used to compute potential correlations between
immunoreactivities and potentially confounding factors. A p value < 0.05 was considered
significant.
3. Results
For NMDA receptor subunits, immunoreactive bands corresponding to molecular masses of
~120 and ~130 kDa for NR1 and NR2C, respectively, were observed (Figure 2). Amounts of
NR1-immunoreactivity from alcohol dependent subjects were significantly lower than those
of control subjects (F5,54 = 9.28, p<0.0001; Figure 3). Post hoc comparisons revealed that
amounts of NR1 immunoreactivity were significantly lower at the rostral and middle LC
(p<0.01) from alcoholics relative to control subjects. In contrast, amounts of NR2C
immunoreactivity from alcohol dependent subjects were not significantly different from that
of controls (Figure 3). PSD-95 and nNOS immunoreactivities appeared as bands with
molecular masses of ~95 and ~160 kDa, respectively, and amounts of these proteins in the LC
of alcoholic subjects were not significantly different from those of control subjects (Figure 2
and 3). TH immunoreactivity appeared as a band at ~60 kDa and amounts of this protein were
normal in alcoholics as compared to controls (Figure 2 and 4). The number of neuromelanin-
containing cell profiles counted at the 3 anatomical levels of the LC was not significantly
different comparing alcoholic to control subjects (Figure 4).
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Ages, postmortem intervals, and brain pH values were not significantly correlated with
amounts of NR1 in control or alcohol dependent subjects. Similarly, effects of age, postmortem
interval, or pH on NR2C, PSD-95, nNOS and TH were not detected. It is worth noting that one
alcohol dependent subject had committed suicide. This subject had an amount of NR1
immunoreactivity near average of immunoreactivity of all alcohol dependent subjects dying
of natural causes. The average body mass index (BMI) values of alcoholics (28.12 ± 2) and
controls (30.6 ± 2) were not significantly different and ranged from 15 to 40 in controls and
19 to 38 in alcoholics (Figure 5).
4. Discussion
To the best of our knowledge, the present study is the first to analyze quantities of glutamate
signaling proteins in postmortem tissue from alcohol dependent subjects. The present study
provides evidence that the amount of the NR1 subunit immunoreactivity is significantly lower
in the LC of alcoholics as compared to healthy controls. In contrast, overall amounts of NR2C,
PSD-95, nNOS and TH were unchanged in the LC of the same alcohol dependent subjects.
Thus, the low level of NR1 subunit was unique among the 5 proteins studied. Based on the
retrospective interviews with next of kin (see Methods) only one of the 10 alcohol dependent
subjects was abstaining from ethanol for 3 weeks before death. Nine of the ten alcoholics were
consuming large quantities of ethanol daily until death. Moreover, toxicology screening
demonstrated the presence of blood and urine ethanol in half of the investigated alcoholics
(Table 1). Therefore, abnormalities in NR1 subunit are likely related to ethanol exposure, rather
than to ethanol withdrawal.
To date, few studies have investigated NMDA receptors in postmortem brain from alcohol
dependent subjects. Radioligand binding to NMDA receptors has been shown to be unchanged
(Dodd et al., 1992; Freund and Anderson, 1999), modestly increased (Freund and Anderson,
1996), or reduced (Cummins et al., 1990; Michaelis et al., 1990) in brains from alcoholics.
However, there has been no previous study of NMDA receptor subunits in postmortem tissue
from alcohol dependent subjects. Rather, investigators have investigated the effects of chronic
exposure of rodents to ethanol on the expression of subunits of the NMDA receptor. Trevisan
et al., (1994) observed up-regulation of NR1 protein in rats exposed to ethanol in the
hippocampus but not in the cortical region, nucleus accumbens or striatum. Snell et al.,
(1996) found increased NR1 protein, but not mRNA, in hippocampus and cerebellum after
chronic ethanol administration to mice. In contrast, unchanged levels of NR1 subunit mRNA
in cortex, hippocampus and cerebellum has been reported in rats chronically treated with
ethanol (Follesa and Ticku, 1995). Overall, these rodent findings are not consistent with the
present observations in postmortem human tissue. This discrepancy between animal and human
studies may be a result of differences in the duration of ethanol exposure. The average age of
alcohol dependent subjects used in the present study is 50 ± 3 y (Table 1). The onset age of
drinking was reported to occur between the teen years and the 20s for alcohol dependent
subjects (see 2.1. Human subjects). Therefore it is estimated that the average duration of
drinking was 20–30 years. Interestingly, a minimum of 6 days of chronic ethanol treatment in
adult rats appeared to be sufficient to observe an up-regulation of NR1 and NR2A-B
polypeptide levels in hippocampus and cerebral cortex (Kalluri et al., 1998; Snell et al.,
1996). Another obvious difference between rodent and human studies is the lack of dietary
control in human studies. Poor diet in alcoholics may contribute to alcohol-induced
neuropathological changes. However, body mass index (BMI), which provides evidence of the
nutritional status, was not statistically different in alcohol dependent subjects as compared to
controls (Figure 5). It is worth noting that both groups of subjects had the BMI values above
25 (ideal BMI). This weight data, albeit limited to the time of death, suggests that malnutrition
is not a factor likely to be contributing to altered NMDA receptor subunit composition.
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Recent studies demonstrate that ethanol has complex regulatory effects on splice variants of
the NR1 subunit. The NR1 subunit has 8 splice variants that are generated by alternative
splicing of single gene exons: 5, 21, and 22 (Zukin and Bennet, 1995). Darstein et al., (2000)
and Hardy et al., (1999) observed reductions in specific splice variants of NR1 mRNA in
ethanol-treated rats during ethanol exposure and after withdrawal, while total amounts of NR1
mRNA were unchanged. In addition, chronic exposure of fetal mouse cortical neurons to
ethanol increases expression of splice variants that lack exon 5 and exon 22, but decreased
expression of splice variants that contain exon 5 (e.g. NR1-3b and NR1-4b). Hence, the effect
of ethanol on NR1 subunits is splice variant-specific. In the present study of alcohol dependent
subjects, the NR1 subunit was measured using an antibody raised against a recombinant fusion
protein containing amino acids 660 to 811, and this antibody does not discriminate the 8 splice
variants of NR1 (Siegel et al., 1994). Hence, it is possible that even more robust effects of
ethanol on NR1 could be found if splice variant-specific antibodies were used.
Based on in vivo and in vitro studies, acute administration of ethanol inhibits the function of
glutamatergic NMDA receptors in regionally specific manner. In contrast, sustained ethanol
administration is associated with 1) increased NMDA receptor function, 2) increased ligand
binding, and 3) elevated levels of protein and/or mRNA for some NMDA receptor subunits in
hippocampus and cerebral cortex (for review see Hoffman, 2003; Krystal et al., 2003; Kumari
and Ticku, 2000). However, no previous study has examined the effect of ethanol
administration on NMDA receptor expression or function in the LC.
Laboratory animal studies have shown that NR2A and NR2B, as opposed to NR2C or NR2D,
are more likely to be regulated by chronic ethanol exposure. NMDA receptors containing
NR2C or NR2D subunits are less sensitive to ethanol-induced inhibition than are those
containing NR2A or NR2B subunits (Chu et al., 1995) suggesting that functional sensitivity
to ethanol may translate to sensitivity to regulation by chronic exposure to ethanol.
Interestingly, among all 32 combinations of NR1/NR2 subunits, the lowest degree of inhibition
by ethanol was observed for NR2C and NR2D receptors containing NR1-3b or NR1-4b
subunits, on the other hand highest degree of inhibition was observed for the NR1-2b/NR2C
receptors (Jin and Woodward, 2006). The functional and pharmacological properties of NR1/
NR2C receptors may depend on NR1 splice variant present and may show marked region-
specific differences. Given that various NR1 splice variants convey differential sensitivity to
ethanol, further study of alcoholism using specific antibodies for protein products of splice
variants of NR1 mRNA in the human LC is warranted.
At excitatory synapses, NMDA receptors are organized into multiprotein signaling complexes.
A prominent scaffolding and anchoring protein is PSD-95 which couples the NMDA to
intracellular proteins and signaling enzymes (Kornau et al. 1995). PSD-95 interacts with the
C terminus of NR2 subunits, but not with NR1 subunits (Lau et al. 1996). As a result, PSD-95
enhances NMDAR clustering at synapses and inhibits NR2-mediated internalization. In the
present study, no differences in the amount of PSD-95 immunoreactivity were observed in
alcoholic compared to control subjects, just as there were no differences in NR2C subunit
immunoreactivity. Presently, there are no previous experimental studies on the effect of chronic
ethanol exposure on PSD-95 levels in the LC. Previously, evidence has been provided that
ethanol withdrawal leads to bi-directional and sex-selective effects on PSD-95 (Alele and
Devaud, 2005). PSD-95 levels were significantly increased in the female rat cerebral cortex
and decreased in the hippocampus by ethanol. This is in contrast to a study reporting that
chronic ethanol administration to neuronal cultures did not alter PSD-95 levels (Chandler et
al., 1999).
The synaptic expression of NR1 subunits, through their C termini, is stabilized by interactions
with calmodulin, alpha-actinin-2, Yotiao or neurofilamin-light (Ehlers et al., 1996; Lin et al.,
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1998; Ratnam and Teichberg, 2005; Wyszynski et al., 1997). Examination of these latter
proteins may provide further insight into the pathology of NR1 signaling machinery in the LC
of alcoholics.
In the CNS, nitric oxide (NO) is predominantly produced by neuronal nitric oxide synthase
(nNOS) and nNOS activity is strongly linked to the NMDA receptor pathway. Studies in
rodents have demonstrated that NO and the nNOS gene are critically involved in the regulation
of neurobehavioral effects of ethanol (Rezvani et al., 1995; Spanagel at al., 2002). However,
in the present study nNOS protein was found unchanged in the LC from alcoholics. A previous
postmortem study has reported that nNOS protein content was significantly increased in the
limbic brain regions such as frontal cortex and nucleus accumbens, but not in the LC in alcohol
dependent subjects (Gerlach et al., 2001). Presently, there are no previous experimental studies
on the effect of chronic ethanol exposure on nNOS protein levels in the LC. nNOS activity has
been measured in rat frontal cortex, hippocampus, striatum and cerebellum following chronic
alcohol exposure (Naassila et al., 1997). The Km and Vmax values were significantly increased
in the frontal cortex and in the striatum, and were not affected in the cerebellum and
hippocampus. In contrast, nNOS activity in the various brain regions of mice remained normal
after acute and chronic administration of ethanol (Ikeda et al., 1999).
Based on reports of reductions in neuron numbers in the LC of alcoholics (Arango et al.,
1994) and in rats exposed to ethanol (Lu et al., 1997), it seemed possible that TH levels and
LC neuron numbers would be low in alcoholics. Instead, we found normal levels of TH and
neuromelanin-containing neurons in all investigated levels of the LC (Figure 2). These findings
are consistent with other postmortem studies reporting no loss of pigmented neurons in
alcoholics (Halliday et al., 1992), and unchanged TH immunoreactivity or TH activity in the
LC of alcoholics (Baker et al., 1994; Tabakoff et al., 1985).
One of the shortcomings of this study is that NR1 protein immunoreactivity was measured in
postmortem tissue homogenates as opposed to measuring functional NR1 subunit protein that
is expressed on the surface of the plasma membrane. Whether the decrease in the total cellular
NR1 protein immunoreactivity is positively correlated with a decrease in the number of
functional subunits expressed on the cell surface cannot be answered based on the present
experiments. Considering that NR1 is an essential subunit of NMDA receptors, it seems
possible that a loss of NR1 subunit may result in a lower number of functional NMDA receptors.
NR1 subunits are synthesized in a large excess (~10-fold) when compared with NR2 subunits
(Huh and Wenthold 1999). The excess production of NR1 optimizes the chance that NR2
subunits will find NR1 partners. Unassembled NR1 subunits with a half-life of approximately
2 h are retained in the endoplasmic reticulum (ER) and degraded. Therefore, there is a
possibility that lower total NR1 protein would indicate increased rate of NR1 protein
degradation in the ER.
Another unresolved issue is the cellular localization of the change of NR1 subunits within the
region of the LC. The LC was dissected with a 5 mm bore punch centered over the cellular
region of the LC. Hence, noradrenergic cells within the LC were collected, as were glia and
terminals of neurons that project to the LC, including serotonergic and GABAergic neurons
(Aston-Jones et al., 1991).
The present findings indicate that amounts of NR1 protein are low in the LC of alcoholic
subjects. A likely causal factor for this neuropathological finding is decades of ethanol
exposure, although improper diet, metabolic abnormalities secondary to liver dysfunction, and
other issues that associate with alcoholism may also contribute. The possibility that reduced
NR1 could be due to alcohol-related structural pathology in the LC seems unlikely based on
findings of unchanged LC cell number as well as normal levels of NR2C, PSD-95, nNOS and
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TH in the same alcohol dependent subjects. Finally, it cannot be ruled out that low NR1 subunit
protein in the LC is a predisposing factor to the development of alcoholism, rather than an
effect of ethanol exposure.
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Relationship between the optical density values of NR1, NR2C, PSD-95, nNOS, TH, actin and
total protein concentration in the human LC. Wells were loaded with 10, 20, and 40 µg of total
human LC protein.
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Immunoblots of NR1, NR2C, PSD-95, nNOS, TH and actin from a representative pair of
control/alcoholic subjects used in the analysis. Shown are blots from three separate anatomical
levels of the LC: rostral (R), middle (M), and caudal (C). Each well was loaded with 20 µg of
total protein. Additionally, each gel was loaded with three concentrations of LC standard
(dissected from a healthy control subject) consisting of 10–40 µg of total protein.
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Amounts of NR1, NR2C, PSD-95, and nNOS immunoreactivities in the LC from control
subjects (open bars; n=8) and alcohol dependent subjects (filled bars; n=10).
Immunoreactivities were measured at the rostral, middle and caudal portions of the LC.
Asterisks indicate statistical significance (p<0.01) Comparing amounts of immunoreactivity
in alcoholic subjects to control subjects at the same anatomical level.
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Amount of TH immunoreactivity and neuromelanin containing cell numbers from control
subjects (open bars; n=8) and alcohol dependent subjects (filled bars; n=10).
Immunoreactivities and LC cell numbers were estimated at the rostral, middle and caudal
portions of the LC.
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Body mass index (BMI) in psychiatrically normal control subjects (open bars, n=8) and in
subjects diagnosed with alcohol dependence (filled bars; n=10). Each bar represents the mean
± SEM. There was no significant difference in BMI comparing alcoholics to control subjects.
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Table 1
Demographics for subjects used in the study.
Parameter Controls (n=8) Alcoholics (n=10)
Age range 27 to 58 y 42 to 64 y
Age (mean±SEM) 44 ± 4 y 50 ± 3 y
PMI rangea 9 to 32 h 14 to 30 h
PMI (mean±SEM) 23 ± 2 22 ± 2
pH range 5.95 to 6.87 5.82 to 6.95
pH (mean±SEM) 6.60 ± 0.11 6.65 ± 0.11
Gender (F:M)b 4:4 2:8
Toxicology Cocaine metabolites, n=1; NDDc, n=7 Lidocaine, n=2; Codeine, n=1; Ethanol, n=5; NDD,
n=2
Natural (heart disease, n=7) Natural (heart disease, n=6; pneumonia, n=2)
Cause of death Accidental (lightning, n=1) Accidental (carbon monoxide poisoning, n=1)





F, female; M, male
c
NDD, no drugs detected
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